Canandaigua National Bank & Trust Co. lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 24.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,477 shares of the healthcare conglomerate's stock after selling 822 shares during the quarter. Canandaigua National Bank & Trust Co.'s holdings in UnitedHealth Group were worth $773,000 at the end of the most recent reporting period.
A number of other hedge funds have also made changes to their positions in UNH. Bayforest Capital Ltd increased its stake in shares of UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd increased its stake in shares of UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after acquiring an additional 50 shares during the period. Copia Wealth Management acquired a new position in UnitedHealth Group in the fourth quarter worth approximately $42,000. IAG Wealth Partners LLC acquired a new position in UnitedHealth Group in the first quarter worth approximately $42,000. Finally, Investment Management Corp VA ADV acquired a new position in UnitedHealth Group in the fourth quarter worth approximately $44,000. Institutional investors and hedge funds own 87.86% of the company's stock.
Wall Street Analyst Weigh In
Several research firms have issued reports on UNH. Hsbc Global Res lowered shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. Oppenheimer decreased their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Wolfe Research lowered their price objective on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 20th. Barclays lifted their price objective on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an "overweight" rating in a research report on Thursday, September 4th. Finally, Baird R W cut shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and a consensus target price of $358.95.
View Our Latest Report on UNH
UnitedHealth Group Stock Down 1.3%
UNH stock opened at $348.05 on Tuesday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The company has a fifty day simple moving average of $292.87 and a 200 day simple moving average of $367.43. The firm has a market cap of $315.22 billion, a PE ratio of 15.08, a PEG ratio of 2.30 and a beta of 0.44.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm's revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the previous year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group's payout ratio is currently 38.30%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.